Exactech Goes Private in $625M Deal With TPG Capital Post author:Sam Post published:October 22, 2017 Post category:BioPharma TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace You Might Also Like Biogen Poaches Merck Exec to Lead New Marketing Team November 2, 2017 uniQure Researchers Swap Out Lead Drug for a Better Prospect October 18, 2017 QIAGEN N.V. Joins CANCER-ID Consortium For Liquid Biopsy Workflows March 30, 2017